Back to search

National and Kapodistrian University of Athens

Μελέτη δεικτών μεθυλίωσης στον καρκίνο των ωοθηκών

Abstract

dc:description

Ovarian cancer is the fourth most common gynecological malignancy and the fifth leading cause of cancer-related mortality in women. It is characterized by a remarkable histological and molecular heterogeneity, with the main subtype being high grade serous ovarian carcinoma (HGSC). This doctoral thesis is focused on DNA methylation of selected genes in clinical samples of patients with HGSC. For all methylation studies, we recruited FFPE samples of primary tumors, adjacent morphologically normal tissues, as well as corresponding plasma samples from the same patients. For the evaluation of methylation, we used two different methodologies, a real-time methylation specific PCR (real-time MSP) for the detection of methylation in tumor and adjacent FFPEs, as well as plasma circulating tumor DNA (ctDNA), and a methylation-sensitive high-resolution melting analysis (MS-HRMA) for the semi-quantitative estimation of methylation in tumor and adjacent FFPEs.At first, in a comparison study, we investigated RASSF1A promoter methylation status in primary tumors, adjacent morphologically normal tissues and corresponding plasma samples of patients with HGSC. In primary tumors and adjacent tissues, RASSF1A promoter methylation was significantly correlated with worse patients’ overall survival (OS). In this study, we reported for the first time that RASSF1A promoter methylation provides significant prognostic information in HGSC patients.We next examined ESR1 methylation in primary tumors and ctDNA of patients with HGSC. In primary tumors, ESR1 methylation was significantly correlated with better patients’ OS and progression free survival (PFS). In this study, we attempted to clarify the role of ESR1 methylation in HGSC.We next performed methylation studies of specific genes involved in molecular pathways which are frequently disrupted in HGSC, such as BRCA1 and MGMT genes involved in different ways in DNA repair, the NR2F1 gene that is actively involved in the establishment of a dormant phenotype, the RASSF10 gene involved in the development of chemoresistance and the RKIP gene involved in the EMT process. After the statistical analysis of the results, we observed a significant correlation between NR2F1 methylation in primary tumors with worse patients’ PFS. Furthermore, BRCA1 methylation in ctDNA was significantly correlated with better PFS. Finally, we estimated PD-L1 gene expression in circulating tumor cells (CTCs) of patients with HGSC, using RT-qPCR. Based on the results of the study, a statistically significant association between PD-L1 gene expression and worse patients’ OS was observed, indicating a possible prognostic significance in HGSC.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Giannopoulou, Lydia
  • Γιαννοπούλου, Λυδία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46777

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Giannopoulou, Lydia; Γιαννοπούλου, Λυδία. Μελέτη δεικτών μεθυλίωσης στον καρκίνο των ωοθηκών. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/46777